{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:19:40Z","timestamp":1790633980129,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T00:00:00Z","timestamp":1401235200000},"content-version":"vor","delay-in-days":300,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.clon.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T16:13:59Z","timestamp":1370362439000},"page":"461-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Focal Therapy for Prostate Cancer: Rationale and Treatment Opportunities"],"prefix":"10.1016","volume":"25","author":[{"given":"V.","family":"Kasivisvanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Emberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.U.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-148-6-200803180-00209","article-title":"Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer","volume":"148","author":"Wilt","year":"2008","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.clon.2013.05.002_bib2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.eururo.2011.11.053","article-title":"A\u00a0critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes","volume":"61","author":"Boorjian","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2002.20.2.557","article-title":"Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer","volume":"20","author":"Wei","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.clon.2013.05.002_bib6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/jnci\/djp278","article-title":"Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986\u20132005","volume":"101","author":"Welch","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.clon.2013.05.002_bib7","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.2004.10.062","article-title":"The changing face of low-risk prostate cancer: trends in clinical presentation and primary management","volume":"22","author":"Cooperberg","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1470-2045(08)70104-9","article-title":"Prostate-cancer mortality in the USA and UK in 1975\u20132004: an ecological study","volume":"9","author":"Collin","year":"2008","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.clon.2013.05.002_bib9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1113135","article-title":"Prostate-cancer mortality at 11 years of follow-up","volume":"366","author":"Schroder","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/djr500","article-title":"Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up","volume":"104","author":"Andriole","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2009.07.018","article-title":"Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)","volume":"56","author":"Roobol","year":"2009","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eururo.2012.10.001","article-title":"Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: results from a population-based study, 2003\u20132011","volume":"63","author":"Nordstrom","year":"2013","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","author":"Wilt","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.eururo.2012.05.072","article-title":"Active surveillance for prostate cancer: a systematic review of the literature","volume":"62","author":"Dall'era","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eururo.2012.08.066","article-title":"Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Goteborg randomised population-based prostate cancer screening trial","volume":"63","author":"Godtman","year":"2013","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cncr.10651","article-title":"Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor","volume":"95","author":"Litwin","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib17","first-page":"551","article-title":"Quality of life, health outcomes, and identity for patients with prostate cancer in five different treatment groups","volume":"28","author":"Galbraith","year":"2001","journal-title":"Oncol Nursing Forum"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1188\/03.ONF.303-309","article-title":"Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer","volume":"30","author":"Wallace","year":"2003","journal-title":"Oncol Nursing Forum"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cncr.21198","article-title":"The role of anxiety in prostate carcinoma: a structured review of the literature","volume":"104","author":"Dale","year":"2005","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.clon.2013.05.002_bib20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1464-410X.2010.09288.x","article-title":"Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry","volume":"106","author":"McVey","year":"2010","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.clon.2013.05.002_bib21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ncponc0959","article-title":"Will focal therapy become a standard of care for men with localized prostate cancer?","volume":"4","author":"Ahmed","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib22","first-page":"2260","article-title":"Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities","volume":"178","author":"Eggener","year":"2007","journal-title":"J\u00a0Urol"},{"issue":"10","key":"10.1016\/j.clon.2013.05.002_bib23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrurol.2010.142","article-title":"Focal therapy in prostate cancer: modalities, findings and future considerations","volume":"7","author":"Lindner","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(12)70121-3","article-title":"Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study","volume":"13","author":"Ahmed","year":"2012","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2012.11.057","article-title":"Morbidity of focal therapy in the treatment of localized prostate cancer","volume":"63","author":"Barret","year":"2013","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.clon.2013.05.002_bib26","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1464-410X.2010.10039.x","article-title":"Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy","volume":"108","author":"Mouraviev","year":"2011","journal-title":"BJU Int"},{"issue":"9","key":"10.1016\/j.clon.2013.05.002_bib27","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/1097-0142(19921101)70:9<2313::AID-CNCR2820700917>3.0.CO;2-T","article-title":"Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors","volume":"70","author":"Villers","year":"1992","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0090-4295(02)01728-4","article-title":"Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens","volume":"60","author":"Wise","year":"2002","journal-title":"Urology"},{"issue":"2 Pt 1","key":"10.1016\/j.clon.2013.05.002_bib29","first-page":"459","article-title":"Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers","volume":"170","author":"Noguchi","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nm.1944","article-title":"Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer","volume":"15","author":"Liu","year":"2009","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.humpath.2011.06.018","article-title":"The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers","volume":"43","author":"Guo","year":"2012","journal-title":"Hum Pathol"},{"issue":"3 Suppl.","key":"10.1016\/j.clon.2013.05.002_bib32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L","article-title":"Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer","volume":"71","author":"Stamey","year":"1993","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1464-410X.2009.08359.x","article-title":"Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy","volume":"104","author":"Ward","year":"2009","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/jjco\/hym173","article-title":"Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer","volume":"38","author":"Muto","year":"2008","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/pcan.2010.16","article-title":"Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy","volume":"14","author":"Karavitakis","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"11","key":"10.1016\/j.clon.2013.05.002_bib37","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.1464-410X.2010.09436.x","article-title":"The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer","volume":"106","author":"Bott","year":"2010","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib38","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.eururo.2008.02.039","article-title":"Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance","volume":"54","author":"van As","year":"2008","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib39","first-page":"780","article-title":"Re: Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities","volume":"180","author":"Ahmed","year":"2008","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.eururo.2012.03.006","article-title":"Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years","volume":"62","author":"Bahn","year":"2012","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.clon.2013.05.002_bib41","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/S1470-2045(12)70307-8","article-title":"Focal HIFU for prostate cancer\u2014authors' reply","volume":"13","author":"Ahmed","year":"2012","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.clon.2013.05.002_bib42","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1200\/JCO.2002.03.061","article-title":"Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer","volume":"20","author":"D'Amico","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.clon.2013.05.002_bib43","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib44","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.urology.2007.06.1101","article-title":"Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer","volume":"70","author":"Stolzenburg","year":"2007","journal-title":"Urology"},{"issue":"17","key":"10.1016\/j.clon.2013.05.002_bib45","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1002\/cncr.27394","article-title":"Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study","volume":"118","author":"Ahmed","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib46","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.urology.2008.03.040","article-title":"Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure","volume":"72","author":"Eisenberg","year":"2008","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1148\/radiol.2362040739","article-title":"Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience","volume":"236","author":"Pucar","year":"2005","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib48","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0360-3016(02)02795-5","article-title":"Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning","volume":"53","author":"Cellini","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib49","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.ijrobp.2011.11.030","article-title":"Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study","volume":"82","author":"Arrayeh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2013.05.002_bib50","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, et\u00a0al. European Association of Urology 2012 guidelines on prostate cancer. Available at: http:\/\/www.uroweb.org\/guidelines\/online-guidelines\/."},{"issue":"7","key":"10.1016\/j.clon.2013.05.002_bib51","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/pros.22622","article-title":"Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens","volume":"73","author":"Crawford","year":"2013","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib52","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1464-410X.2012.10933.x","article-title":"A\u00a0biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy","volume":"110","author":"Hu","year":"2012","journal-title":"BJU Int"},{"issue":"26","key":"10.1016\/j.clon.2013.05.002_bib53","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1200\/JCO.2008.20.3497","article-title":"Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management","volume":"27","author":"Onik","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.urology.2008.03.022","article-title":"Stereotactic transperineal prostate biopsy","volume":"73","author":"Moran","year":"2009","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.clon.2013.05.002_bib55","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/cncr.21020","article-title":"Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy","volume":"103","author":"Demura","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib56","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.urology.2004.10.067","article-title":"Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience","volume":"65","author":"Pinkstaff","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib57","first-page":"860","article-title":"Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer","volume":"189","author":"Kasivisvanathan","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MOU.0b013e328011b85c","article-title":"Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer","volume":"17","author":"Pallwein","year":"2007","journal-title":"Curr Opin Urol"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib59","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.eururo.2008.02.035","article-title":"Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy","volume":"54","author":"Salomon","year":"2008","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.clon.2013.05.002_bib60","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/j.1464-410X.2011.10199.x","article-title":"Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling","volume":"108","author":"Taverna","year":"2011","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-410X.2011.10734.x","article-title":"Detection, localisation and characterisation of prostate cancer by prostate HistoScanning","volume":"110","author":"Simmons","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.clon.2013.05.002_bib62","first-page":"584","article-title":"Impact of real-time elastography versus systematic prostate biopsy method on cancer detection rate in men with a serum prostate-specific antigen between 2.5 and 10\u2009\u00a0ng\/ml","volume":"2013","author":"Taverna","year":"2012","journal-title":"ISRN Oncology"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib63","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.urology.2009.04.102","article-title":"Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens","volume":"74","author":"Puech","year":"2009","journal-title":"Urology"},{"issue":"6 Pt 1","key":"10.1016\/j.clon.2013.05.002_bib64","first-page":"2432","article-title":"Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings","volume":"176","author":"Villers","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib65","doi-asserted-by":"crossref","first-page":"W316","DOI":"10.2214\/AJR.09.2651","article-title":"Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy","volume":"194","author":"Woodfield","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib66","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2214\/AJR.10.4441","article-title":"Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy","volume":"196","author":"Verma","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib67","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1148\/radiol.2343040363","article-title":"Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy","volume":"234","author":"Zakian","year":"2005","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib68","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib69","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.eururo.2010.12.009","article-title":"Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting","volume":"59","author":"Dickinson","year":"2011","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib70","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2012.06.044","article-title":"Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients","volume":"62","author":"Portalez","year":"2012","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib71","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2214\/AJR.12.8725","article-title":"MRI-guided interventions for the treatment of prostate cancer","volume":"199","author":"Bomers","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"Pt 1","key":"10.1016\/j.clon.2013.05.002_bib72","first-page":"455","article-title":"Development of an MRI-compatible device for prostate focal therapy","volume":"15","author":"Cepek","year":"2012","journal-title":"Med Image Comput Comput Assist Interv"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib73","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.5489\/cuaj.138","article-title":"Focal magnetic resonance guided focused ultrasound for prostate cancer: Initial North American experience","volume":"6","author":"Lindner","year":"2012","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib74","first-page":"1246","article-title":"Focal therapy for localized prostate cancer: a phase I\/II trial","volume":"185","author":"Ahmed","year":"2011","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib75","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S1677-55382011000200008","article-title":"Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up","volume":"37","author":"El Fegoun","year":"2011","journal-title":"Int Braz J Urol"},{"issue":"9","key":"10.1016\/j.clon.2013.05.002_bib76","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1089\/end.2006.20.688","article-title":"Focal prostate cryoablation: initial results show cancer control and potency preservation","volume":"20","author":"Bahn","year":"2006","journal-title":"J\u00a0Endourol"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib77","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.urology.2007.02.047","article-title":"Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer","volume":"69","author":"Lambert","year":"2007","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib78","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.urology.2006.10.024","article-title":"Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation","volume":"69","author":"Ellis","year":"2007","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib79","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.urolonc.2008.03.004","article-title":"The \u201cmale lumpectomy\u201d: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up","volume":"26","author":"Onik","year":"2008","journal-title":"Urol Oncol"},{"issue":"8723","key":"10.1016\/j.clon.2013.05.002_bib80","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0140-6736(90)92626-S","article-title":"Photodynamic therapy of localised prostatic cancer","volume":"336","author":"Windahl","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2013.05.002_bib81","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1078\/1615-1615-00092","article-title":"Photodynamic therapy by means of 5-ALA induced PPIX in human prostate cancer\u2014preliminary results","volume":"18","author":"Zaak","year":"2003","journal-title":"Med Laser Appl"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib82","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/lsm.20275","article-title":"Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer","volume":"38","author":"Moore","year":"2006","journal-title":"Lasers Surg Med"},{"issue":"791","key":"10.1016\/j.clon.2013.05.002_bib83","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1259\/0007-1285-66-791-1044","article-title":"Technical note: interstitial laser photocoagulation for the treatment of prostatic cancer","volume":"66","author":"Amin","year":"1993","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib84","first-page":"1371","article-title":"Image guided photothermal focal therapy for localized prostate cancer: phase I trial","volume":"182","author":"Lindner","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib85","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.eururo.2010.03.008","article-title":"Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy","volume":"57","author":"Lindner","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eururo.2010.03.006","article-title":"Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer","volume":"58","author":"Raz","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib87","first-page":"69","article-title":"First robotic magnetic resonance-guided laser focal therapy for prostate cancer: a case report and review of the literature","volume":"1","author":"Lindner","year":"2011","journal-title":"Interven Oncol Soc J"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib88","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0090-4295(03)00772-6","article-title":"Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate","volume":"62","author":"D'Amico","year":"2003","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib89","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/cncr.11595","article-title":"Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy","volume":"98","author":"Albert","year":"2003","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib90","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2012.04.028","article-title":"Feasibility of MR imaging\/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer","volume":"85","author":"Hsu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1148\/radiol.2471061982","article-title":"Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy \u2013 initial experience","volume":"247","author":"McKenna","year":"2008","journal-title":"Radiology"},{"issue":"Suppl. 1","key":"10.1016\/j.clon.2013.05.002_bib92","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1464-410X.2011.10825.x","article-title":"Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer","volume":"109","author":"Langley","year":"2012","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib93","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2008.11.023","article-title":"Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study","volume":"75","author":"Ares","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib94","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ijrobp.2007.11.067","article-title":"Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations","volume":"70","author":"Fuller","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2013.05.002_bib95","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2008.05.059","article-title":"Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial","volume":"73","author":"King","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib96","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/pros.20242","article-title":"Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer","volume":"65","author":"Shariat","year":"2005","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib97","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0090-4295(97)00540-2","article-title":"Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination","volume":"50","author":"Djavan","year":"1997","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib98","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jvir.2010.12.014","article-title":"Investigation of the safety of irreversible electroporation in humans","volume":"22","author":"Thomson","year":"2011","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"6","key":"10.1016\/j.clon.2013.05.002_bib99","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00270-012-0363-7","article-title":"Irreversible electroporation for focal ablation at the porta hepatis","volume":"35","author":"Kasivisvanathan","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"8","key":"10.1016\/j.clon.2013.05.002_bib100","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3109\/02656736.2010.485593","article-title":"Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy","volume":"26","author":"Krishnan","year":"2010","journal-title":"Int J Hyperthermia"},{"issue":"2","key":"10.1016\/j.clon.2013.05.002_bib101","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiol.11101489","article-title":"Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced US","volume":"259","author":"Rouviere","year":"2011","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib102","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000049786","article-title":"MRI appearance of prostate following transrectal HIFU ablation of localized cancer","volume":"40","author":"Rouviere","year":"2001","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib103","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00330-009-1520-5","article-title":"Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI","volume":"20","author":"Rouviere","year":"2010","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.clon.2013.05.002_bib104","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00330-009-1647-4","article-title":"Imaging of prostate cancer local recurrences: why and how?","volume":"20","author":"Rouviere","year":"2010","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.clon.2013.05.002_bib105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1148\/radiol.2463062080","article-title":"MR imaging of prostate after treatment with high-intensity focused ultrasound","volume":"246","author":"Kirkham","year":"2008","journal-title":"Radiology"},{"issue":"6 Suppl.","key":"10.1016\/j.clon.2013.05.002_bib106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2007.07.036","article-title":"Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results","volume":"70","author":"Ellis","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.clon.2013.05.002_bib107","first-page":"223","article-title":"Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization","volume":"157","author":"Gburek","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clon.2013.05.002_bib108","doi-asserted-by":"crossref","first-page":"c1066","DOI":"10.1136\/bmj.c1066","article-title":"Rethinking pragmatic randomised controlled trials: introducing the \u201ccohort multiple randomised controlled trial\u201d design","volume":"340","author":"Relton","year":"2010","journal-title":"Br Med J"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655513002197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655513002197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:39:52Z","timestamp":1760542792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655513002197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":108,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0936655513002197"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2013.05.002","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focal Therapy for Prostate Cancer: Rationale and Treatment Opportunities","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2013.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Royal College of Radiologists. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}